TwinBeech Capital’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-49,634
Closed -$596K 581
2023
Q4
$596K Sell
49,634
-96,269
-66% -$789K 0.01% 535
2023
Q3
$1.02M Sell
145,903
-3,511
-2% -$32.4K 0.02% 487
2023
Q2
$1.27M Buy
+149,414
New +$1.25M 0.03% 432
2021
Q4
Sell
-4,700
Closed -$298K 594
2021
Q3
$298K Buy
+4,700
New +$358K 0.02% 502
2020
Q1
Sell
-12,581
Closed -$271K 312
2019
Q4
$271K Buy
+12,581
New +$289K 0.08% 313

Other funds holding CDNA

TwinBeech Capital's CDNA Position: Q1 2024 in Review

TwinBeech Capital sold out of CareDx (CDNA) in Q1 2024, closing a stake of 49,634 shares — an estimated $596K sold.

TwinBeech Capital first reported a position in CDNA in Q4 2019 and held it in 5 quarters. The position peaked at $1.27M in Q2 2023. 147 funds tracked by Wall St. Rank hold CDNA as of Q1 2024.

  • TwinBeech Capital reported no remaining CareDx position as of Q1 2024 after selling out during the quarter.
  • TwinBeech Capital sold 49,634 CareDx shares in Q1 2024, an estimated $596K.
  • TwinBeech Capital first reported a position in CareDx in Q4 2019 and held it in 5 quarters.
  • TwinBeech Capital's CareDx position peaked at $1.27M in Q2 2023.
  • 147 funds tracked by Wall St. Rank held CareDx as of Q1 2024.

Based on TwinBeech Capital's 13F filing for Q1 2024, filed 15 May 2024.